scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0735-1097(10)80029-4 |
P698 | PubMed publication ID | 2329241 |
P2093 | author name string | R Virmani | |
C Gold | |||
G L Schaer | |||
M S Visner | |||
E C Santoian | |||
S P Karas | |||
P2860 | cites work | Platelet trapping in myocardial infarct in baboons: therapeutic effect of aspirin | Q71322367 |
Fluorocarbons reduce myocardial ischemic damage after coronary occlusion | Q71492786 | ||
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog | Q71682222 | ||
Kinetics and imaging of indium-11-labeled autologous platelets in experimental myocardial infarction | Q71726137 | ||
The use of single plane angiocardiograms for the calculation of left ventricular volume in man | Q72023273 | ||
Myocardial reperfusion: a double-edged sword? | Q28236054 | ||
Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction | Q33821794 | ||
The "no-reflow" phenomenon after temporary coronary occlusion in the dog. | Q34471387 | ||
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology | Q34606745 | ||
Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion | Q35810373 | ||
Can superoxide dismutase alter myocardial infarct size? | Q38625209 | ||
Myocardial platelet trapping after coronary ligation in primates (Papio anubis). | Q39666842 | ||
Amphipathic metabolites and membrane dysfunction in ischemic myocardium | Q40076674 | ||
The stunned myocardium: prolonged, postischemic ventricular dysfunction | Q40246508 | ||
Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%. | Q44293269 | ||
Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty | Q44498506 | ||
Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model | Q47196223 | ||
Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart | Q47196496 | ||
Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion | Q47204619 | ||
Limitation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardium | Q47208118 | ||
Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion | Q47225571 | ||
Effect of fluocarbon exchange transfusion on myocardial infarction size in dogs | Q47252441 | ||
Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique | Q47282887 | ||
Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. | Q51827797 | ||
Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol. | Q54105007 | ||
Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. | Q64997881 | ||
Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury | Q67969208 | ||
Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo | Q68091009 | ||
Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation | Q69329614 | ||
Oxygen consumption and coronary reactivity in postischemic myocardium | Q69934332 | ||
Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions | Q70021482 | ||
Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion | Q70055416 | ||
Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion | Q70058758 | ||
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial | Q70331348 | ||
Effects of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tensions | Q70361804 | ||
The interactions of platelet-derived mediators on isolated canine coronary arteries | Q70511432 | ||
Role of free radicals in catecholamine-induced cardiomyopathy | Q70538562 | ||
Effects of perfluorochemical on phagocytic function of leukocytes | Q71119675 | ||
Maintenance of aerobic metabolism during global ischemia with perfluorocarbon cardioplegia improves myocardial preservation | Q71257162 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
reperfusion injury | Q1413991 | ||
P304 | page(s) | 1385-1393 | |
P577 | publication date | 1990-05-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction. | |
P478 | volume | 15 |
Q48833015 | Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery |
Q40588885 | Cardiovascular applications of fluorocarbons in regional ischemia/reperfusion |
Q47241818 | Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion |
Q40466595 | Fluorocarbon emulsions |
Q35185199 | Myocardial Oxygen Supply under Critical Conditions, the Effects of Hemodilution and Fluorocarbons |
Q35684768 | Myocardial protection during coronary angioplasty |
Search more.